Effect of Prebiotic FOS on Intestinal Abundance of Faecalibacterium Prausnitzii in Patients With Crohn´s Disease

NCT02539849 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Crohn Disease

Interventions

DIETARY_SUPPLEMENT: FOS
DRUG: Adalimumab

Sponsor

Hospital Universitari Vall d'Hebron Research Institute

Collaborators

[object Object]